{"pmid":32350871,"title":"Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic.","text":["Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic.","OBJECTIVE: To study vaginal delivery outcomes and neonatal prognosis and summarize the management of vaginal delivery during the COVID-19 pandemic. METHODS: A retrospective analysis of medical records and comparison of vaginal delivery outcomes between 10 pregnant women with clinical diagnosis of COVID-19 and 53 pregnant women without COVID-19 admitted to Zhongnan Hospital of Wuhan University between January 20 and March 2, 2020. Results of laboratory tests, imaging tests, and SARS-CoV-2 nucleic acid tests were also analyzed in neonates delivered by pregnant women with clinical diagnosis of COVID-19. RESULTS: There were no significant differences in gestational age, postpartum hemorrhage, and perineal resection rates between the two groups. There were no significant differences in birth weight of neonates and neonatal asphyxia rates between the two groups. Neonates delivered by pregnant women with clinical diagnosis of COVID-19 tested negative for SARS-CoV-2 infection. CONCLUSIONS: Under the premise of full evaluation of vaginal delivery conditions and strict protection measures, pregnant women with ordinary type COVID-19 can try vaginal delivery without exacerbation of COVID-19 and without increasing the risk of SARS-CoV-2 infection in neonates.","Int J Gynaecol Obstet","Liao, Jing","He, Xiaoyan","Gong, Qing","Yang, Lingyun","Zhou, Chunhua","Li, Jiafu","32350871"],"abstract":["OBJECTIVE: To study vaginal delivery outcomes and neonatal prognosis and summarize the management of vaginal delivery during the COVID-19 pandemic. METHODS: A retrospective analysis of medical records and comparison of vaginal delivery outcomes between 10 pregnant women with clinical diagnosis of COVID-19 and 53 pregnant women without COVID-19 admitted to Zhongnan Hospital of Wuhan University between January 20 and March 2, 2020. Results of laboratory tests, imaging tests, and SARS-CoV-2 nucleic acid tests were also analyzed in neonates delivered by pregnant women with clinical diagnosis of COVID-19. RESULTS: There were no significant differences in gestational age, postpartum hemorrhage, and perineal resection rates between the two groups. There were no significant differences in birth weight of neonates and neonatal asphyxia rates between the two groups. Neonates delivered by pregnant women with clinical diagnosis of COVID-19 tested negative for SARS-CoV-2 infection. CONCLUSIONS: Under the premise of full evaluation of vaginal delivery conditions and strict protection measures, pregnant women with ordinary type COVID-19 can try vaginal delivery without exacerbation of COVID-19 and without increasing the risk of SARS-CoV-2 infection in neonates."],"journal":"Int J Gynaecol Obstet","authors":["Liao, Jing","He, Xiaoyan","Gong, Qing","Yang, Lingyun","Zhou, Chunhua","Li, Jiafu"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32350871","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ijgo.13188","keywords":["covid-19","china","management","neonatal outcome","pregnancy","vaginal delivery"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis","Transmission"],"weight":1,"_version_":1666138495633063938,"score":9.490897,"similar":[{"pmid":32271947,"title":"Delivery in pregnant women infected with SARS-CoV-2: A fast review.","text":["Delivery in pregnant women infected with SARS-CoV-2: A fast review.","BACKGROUND: Few case reports and clinical series exist on pregnant women infected with SARS-CoV-2 who delivered. OBJECTIVE: To review the available information on mode of delivery, vertical/peripartum transmission, and neonatal outcome in pregnant women infected with SARS-CoV-2. SEARCH STRATEGY: Combination of the following key words: COVID-19, SARS-CoV-2, and pregnancy in Embase and PubMed databases. SELECTION CRITERIA: Papers reporting cases of women infected with SARS-CoV-2 who delivered. DATA COLLECTION AND ANALYSIS: The following was extracted: author; country; number of women; study design; gestational age at delivery; selected clinical maternal data; mode of delivery; selected neonatal outcomes. MAIN RESULTS: In the 13 studies included, vaginal delivery was reported in 6 cases (9.4%; 95% CI, 3.5-19.3). Indication for cesarean delivery was worsening of maternal conditions in 31 cases (48.4%; 95% CI, 35.8-61.3). Two newborns testing positive for SARS-CoV-2 by real-time RT-PCR assay were reported. In three neonates, SARS-CoV-2 IgG and IgM levels were elevated but the RT-PCR test was negative. CONCLUSIONS: The rate of vertical or peripartum transmission of SARS-CoV-2 is low, if any, for cesarean delivery; no data are available for vaginal delivery. Low frequency of spontaneous preterm birth and general favorable immediate neonatal outcome are reassuring.","Int J Gynaecol Obstet","Parazzini, Fabio","Bortolus, Renata","Mauri, Paola Agnese","Favilli, Alessandro","Gerli, Sandro","Ferrazzi, Enrico","32271947"],"abstract":["BACKGROUND: Few case reports and clinical series exist on pregnant women infected with SARS-CoV-2 who delivered. OBJECTIVE: To review the available information on mode of delivery, vertical/peripartum transmission, and neonatal outcome in pregnant women infected with SARS-CoV-2. SEARCH STRATEGY: Combination of the following key words: COVID-19, SARS-CoV-2, and pregnancy in Embase and PubMed databases. SELECTION CRITERIA: Papers reporting cases of women infected with SARS-CoV-2 who delivered. DATA COLLECTION AND ANALYSIS: The following was extracted: author; country; number of women; study design; gestational age at delivery; selected clinical maternal data; mode of delivery; selected neonatal outcomes. MAIN RESULTS: In the 13 studies included, vaginal delivery was reported in 6 cases (9.4%; 95% CI, 3.5-19.3). Indication for cesarean delivery was worsening of maternal conditions in 31 cases (48.4%; 95% CI, 35.8-61.3). Two newborns testing positive for SARS-CoV-2 by real-time RT-PCR assay were reported. In three neonates, SARS-CoV-2 IgG and IgM levels were elevated but the RT-PCR test was negative. CONCLUSIONS: The rate of vertical or peripartum transmission of SARS-CoV-2 is low, if any, for cesarean delivery; no data are available for vaginal delivery. Low frequency of spontaneous preterm birth and general favorable immediate neonatal outcome are reassuring."],"journal":"Int J Gynaecol Obstet","authors":["Parazzini, Fabio","Bortolus, Renata","Mauri, Paola Agnese","Favilli, Alessandro","Gerli, Sandro","Ferrazzi, Enrico"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271947","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ijgo.13166","keywords":["covid-19","cesarean delivery","neonatal outcome","pregnancy","review","sars-cov-2","vaginal delivery","vertical transmission"],"topics":["Transmission"],"weight":1,"_version_":1666138491864481792,"score":768.81525},{"pmid":32369656,"title":"Coronavirus disease 2019 among pregnant Chinese women: Case series data on the safety of vaginal birth and breastfeeding.","text":["Coronavirus disease 2019 among pregnant Chinese women: Case series data on the safety of vaginal birth and breastfeeding.","OBJECTIVE: To assess whether vaginal secretions and breast milk of COVID-19 patients contain SARS-CoV-2 virus. DESIGN: Single center cohort study. SETTING: Renmin Hospital of Wuhan University, Wuhan, Hubei province, China. POPULATION OR SAMPLE: We studied 13 COVID-19 infected pregnant women diagnosed between January 31 and March 9, 2020. METHODS: We collected clinical data, vaginal secretions and stool specimens, breast milk from COVID-19 infected women during different stages of pregnancy and neonatal throat, anal swabs. MAIN OUTCOME(S) AND MEASURE(S): We assessed viral presence in different biosamples. RESULTS: Of the 13 women with COVID-19, 5 were in their first trimester, 3 in their second trimester, and 5 in their third trimester. Of the 5 women during their third trimester who gave birth, all delivered live newborns. Among these 5 deliveries, the primary adverse perinatal outcomes included premature delivery (n = 2) and neonatal pneumonia (n = 2). One of 9 stool samples was positive; and all 13 vaginal secretion samples, and 5 throat swabs and 4 anal swabs collected from newborns were negative for the novel coronavirus. However, 1 of 3 samples of breast milk was positive by viral nucleic acid testing. CONCLUSIONS: In this case series of 13 pregnant women with COVID-19, we observed negative viral test results in vaginal secretion specimens, suggesting that a vaginal delivery may be a safe delivery option. However, additional research is urgently needed to examine breast milk and the potential risk for viral contamination.","BJOG","Wu, Yanting","Liu, Chen","Dong, Lan","Zhang, Chenjie","Chen, Yang","Liu, Jun","Zhang, Chen","Duan, Chenchi","Zhang, Hanqiu","Mol, Ben W","Dennis, Cindy-Lee","Yin, Tailang","Yang, Jing","Huang, Hefeng","32369656"],"abstract":["OBJECTIVE: To assess whether vaginal secretions and breast milk of COVID-19 patients contain SARS-CoV-2 virus. DESIGN: Single center cohort study. SETTING: Renmin Hospital of Wuhan University, Wuhan, Hubei province, China. POPULATION OR SAMPLE: We studied 13 COVID-19 infected pregnant women diagnosed between January 31 and March 9, 2020. METHODS: We collected clinical data, vaginal secretions and stool specimens, breast milk from COVID-19 infected women during different stages of pregnancy and neonatal throat, anal swabs. MAIN OUTCOME(S) AND MEASURE(S): We assessed viral presence in different biosamples. RESULTS: Of the 13 women with COVID-19, 5 were in their first trimester, 3 in their second trimester, and 5 in their third trimester. Of the 5 women during their third trimester who gave birth, all delivered live newborns. Among these 5 deliveries, the primary adverse perinatal outcomes included premature delivery (n = 2) and neonatal pneumonia (n = 2). One of 9 stool samples was positive; and all 13 vaginal secretion samples, and 5 throat swabs and 4 anal swabs collected from newborns were negative for the novel coronavirus. However, 1 of 3 samples of breast milk was positive by viral nucleic acid testing. CONCLUSIONS: In this case series of 13 pregnant women with COVID-19, we observed negative viral test results in vaginal secretion specimens, suggesting that a vaginal delivery may be a safe delivery option. However, additional research is urgently needed to examine breast milk and the potential risk for viral contamination."],"journal":"BJOG","authors":["Wu, Yanting","Liu, Chen","Dong, Lan","Zhang, Chenjie","Chen, Yang","Liu, Jun","Zhang, Chen","Duan, Chenchi","Zhang, Hanqiu","Mol, Ben W","Dennis, Cindy-Lee","Yin, Tailang","Yang, Jing","Huang, Hefeng"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369656","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/1471-0528.16276","keywords":["covid-19","breast milk","vaginal secretions"],"locations":["Wuhan","Hubei","China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1666138496159449088,"score":696.46277},{"pmid":32339382,"title":"Vaginal delivery in SARS-CoV-2 infected pregnant women in Northern Italy: a retrospective analysis.","text":["Vaginal delivery in SARS-CoV-2 infected pregnant women in Northern Italy: a retrospective analysis.","OBJECTIVE: To report mode of delivery and immediate neonatal outcome in COVID-19 infected women. DESIGN: This is a retrospective study. SETTING: Twelve hospitals in northern Italy. PARTICIPANTS: Pregnant women with COVID-19 confirmed infection who delivered. EXPOSURE: COVID 19 infection in pregnancy. METHODS: SARS-CoV-2 infected women who were admitted and delivered during the period 1-20 march 2020 were eligible. Data were collected from the clinical records using a standardized questionnaire on maternal general characteristics, any medical or obstetric co-morbidity, course of pregnancy, clinical signs and symptoms, treatment of COVID 19 infection, mode of delivery, neonatal data and breastfeeding MAIN OUTCOME AND MEASURE: Data on mode of delivery and neonatal outcome RESULTS: 42 women with COVID-19 delivered at the participating centres: 24(57,1%, 95% CI= 41,0-72,3) delivered vaginally. An elective cesarean section was performed in 18/42 (42,9%, 95%CI 27,7-59,0) cases: in 8 cases the indication was unrelated to COVID-19 infection. Pneumonia was diagnosed in 19/42(45,2%, 95%CI 29,8-61,3) cases: of these 7/19(36,8%,95CI 16,3-61,6) required oxygen support and 4/19(21,1%,95%CI=6,1-45,6) were admitted to a critical care unit. Two women with COVID-19 breastfed without a mask because infection was diagnosed in the post-partum period: their new-borns tested positive for SARS-Cov-2 infection. In one case a new-born had a positive test after a vaginal operative delivery. CONCLUSIONS: Although post-partum infection cannot be excluded with 100% certainty, these findings suggest that vaginal delivery is associated with a low risk of intrapartum SARS-Cov-2 transmission to the new-born.","BJOG","Ferrazzi, Enrico","Frigerio, Luigi","Savasi, Valeria","Vergani, Patrizia","Prefumo, Federico","Barresi, Santa","Bianchi, Stefano","Ciriello, Elena","Facchinetti, Fabio","Gervasi, Maria Teresa","Iurlaro, Enrico","Kustermann, Alessandra","Mangili, Giovanna","Mosca, Fabio","Patane, Luisa","Spazzini, Donata","Spinillo, Arsenio","Trojano, Giuseppe","Vignali, Michele","Villa, Antonella","Zuccotti, GianVincenzo","Parazzini, Fabio","Cetin, Irene","32339382"],"abstract":["OBJECTIVE: To report mode of delivery and immediate neonatal outcome in COVID-19 infected women. DESIGN: This is a retrospective study. SETTING: Twelve hospitals in northern Italy. PARTICIPANTS: Pregnant women with COVID-19 confirmed infection who delivered. EXPOSURE: COVID 19 infection in pregnancy. METHODS: SARS-CoV-2 infected women who were admitted and delivered during the period 1-20 march 2020 were eligible. Data were collected from the clinical records using a standardized questionnaire on maternal general characteristics, any medical or obstetric co-morbidity, course of pregnancy, clinical signs and symptoms, treatment of COVID 19 infection, mode of delivery, neonatal data and breastfeeding MAIN OUTCOME AND MEASURE: Data on mode of delivery and neonatal outcome RESULTS: 42 women with COVID-19 delivered at the participating centres: 24(57,1%, 95% CI= 41,0-72,3) delivered vaginally. An elective cesarean section was performed in 18/42 (42,9%, 95%CI 27,7-59,0) cases: in 8 cases the indication was unrelated to COVID-19 infection. Pneumonia was diagnosed in 19/42(45,2%, 95%CI 29,8-61,3) cases: of these 7/19(36,8%,95CI 16,3-61,6) required oxygen support and 4/19(21,1%,95%CI=6,1-45,6) were admitted to a critical care unit. Two women with COVID-19 breastfed without a mask because infection was diagnosed in the post-partum period: their new-borns tested positive for SARS-Cov-2 infection. In one case a new-born had a positive test after a vaginal operative delivery. CONCLUSIONS: Although post-partum infection cannot be excluded with 100% certainty, these findings suggest that vaginal delivery is associated with a low risk of intrapartum SARS-Cov-2 transmission to the new-born."],"journal":"BJOG","authors":["Ferrazzi, Enrico","Frigerio, Luigi","Savasi, Valeria","Vergani, Patrizia","Prefumo, Federico","Barresi, Santa","Bianchi, Stefano","Ciriello, Elena","Facchinetti, Fabio","Gervasi, Maria Teresa","Iurlaro, Enrico","Kustermann, Alessandra","Mangili, Giovanna","Mosca, Fabio","Patane, Luisa","Spazzini, Donata","Spinillo, Arsenio","Trojano, Giuseppe","Vignali, Michele","Villa, Antonella","Zuccotti, GianVincenzo","Parazzini, Fabio","Cetin, Irene"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339382","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/1471-0528.16278","keywords":["covid-19","delivery","transmission"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis","Treatment","Transmission"],"weight":1,"_version_":1666138494205952002,"score":662.4851},{"pmid":32145714,"title":"[Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province].","text":["[Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province].","Objective: To study the effect of COVID-19 on pregnancy outcomes and neonatal prognosis in Hubei Province. Methods: A retrospective comparison of the pregnancy outcomes was done between 16 women with COVID-19 and 45 women without COVID-19. Also, the results of laboratory tests, imaging examinations, and the 2019-nCoV nucleic acid test were performed in 10 cases of neonatal deliverd from women with COVID-19. Results: (1) Of the 16 pregnant women with COVID-19, 15 cases were ordinary type and 1 case was severe type. No one has progressed to critical pneumonia. The delivery method of the two groups was cesarean section, and the gestational age were (38.7+/-1.4) and (37.9+/-1.6) weeks, there was no significant difference between the two groups (P> 0.05). Also, there wee no significant differences in the intraoperative blood loss and birth weight of the newborn between the two groups (all P>0.05). (2) Ten cases of neonates delivered from pregnant women with COVID-19 were collected. The 2019-nCoV nucleic acid test were all negative. There were no significant differences in fetal distress, meconium-stained amniotic fluid, preterm birth, and neonatal asphyxia between the two groups (all P>0.05). (3) In the treatment of uterine contraction fatigue, carbetocin or carboprost tromethamine was used more in cesarean section for pregnant women with COVID-19 (1.3+/-0.6), compared with Non-COVID-19 group (0.5+/-0.7), the difference was statistically significant (P=0.001). Conclusions: If there is an indication for obstetric surgery or critical illness of COVID-19 in pregnant women, timely termination of pregnancy will not increase the risk of premature birth and asphyxia of the newborn, but it is beneficial to the treatment and rehabilitation of maternal pneumonia. Preventive use of long-acting uterotonic agents could reduce the incidence of postpartum hemorrhage during surgery. 2019-nCoV infection has not been found in neonates deliverd from pregnant women with COVID-19.","Zhonghua Fu Chan Ke Za Zhi","Zhang, L","Jiang, Y","Wei, M","Cheng, B H","Zhou, X C","Li, J","Tian, J H","Dong, L","Hu, R H","32145714"],"abstract":["Objective: To study the effect of COVID-19 on pregnancy outcomes and neonatal prognosis in Hubei Province. Methods: A retrospective comparison of the pregnancy outcomes was done between 16 women with COVID-19 and 45 women without COVID-19. Also, the results of laboratory tests, imaging examinations, and the 2019-nCoV nucleic acid test were performed in 10 cases of neonatal deliverd from women with COVID-19. Results: (1) Of the 16 pregnant women with COVID-19, 15 cases were ordinary type and 1 case was severe type. No one has progressed to critical pneumonia. The delivery method of the two groups was cesarean section, and the gestational age were (38.7+/-1.4) and (37.9+/-1.6) weeks, there was no significant difference between the two groups (P> 0.05). Also, there wee no significant differences in the intraoperative blood loss and birth weight of the newborn between the two groups (all P>0.05). (2) Ten cases of neonates delivered from pregnant women with COVID-19 were collected. The 2019-nCoV nucleic acid test were all negative. There were no significant differences in fetal distress, meconium-stained amniotic fluid, preterm birth, and neonatal asphyxia between the two groups (all P>0.05). (3) In the treatment of uterine contraction fatigue, carbetocin or carboprost tromethamine was used more in cesarean section for pregnant women with COVID-19 (1.3+/-0.6), compared with Non-COVID-19 group (0.5+/-0.7), the difference was statistically significant (P=0.001). Conclusions: If there is an indication for obstetric surgery or critical illness of COVID-19 in pregnant women, timely termination of pregnancy will not increase the risk of premature birth and asphyxia of the newborn, but it is beneficial to the treatment and rehabilitation of maternal pneumonia. Preventive use of long-acting uterotonic agents could reduce the incidence of postpartum hemorrhage during surgery. 2019-nCoV infection has not been found in neonates deliverd from pregnant women with COVID-19."],"journal":"Zhonghua Fu Chan Ke Za Zhi","authors":["Zhang, L","Jiang, Y","Wei, M","Cheng, B H","Zhou, X C","Li, J","Tian, J H","Dong, L","Hu, R H"],"date":"2020-03-09T11:00:00Z","year":2020,"_id":"32145714","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.3760/cma.j.cn112141-20200218-00111","keywords":["2019-ncov","covid-19","neonates","pneumonia","pregnancy outcomes"],"locations":["Hubei","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["carbetocin","carboprost tromethamine"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490680639489,"score":641.9453},{"pmid":32353549,"pmcid":"PMC7185021","title":"Coronavirus disease 2019 in pregnancy.","text":["Coronavirus disease 2019 in pregnancy.","OBJECTIVES: This study aims to compare clinical course and outcomes between pregnant and reproductive-aged non-pregnant women with COVID-19 and assess the vertical transmission potential of COVID-19 in pregnancy. METHODS: Medical records of pregnant and reproductive-aged non-pregnant women hospitalized with COVID-19 from January 15 to March 15, 2020, were retrospectively reviewed. The severity of disease, virus clearance time, and length of hospital stay were measured as the primary interest and the vertical transmission potential of COVID-19 was also assessed. RESULTS: Eighty-two patients (28 pregnant women, 54 reproductive-aged non-pregnant women) with laboratory confirmed COVID-19 were enrolled in this study. Univariate regression indicated no association between pregnancy and the severity of disease (OR 0.73, 95% CI 0.08-5.15; p=0.76), virus clearance time (HR 1.16, 95% CI 0.65-2.01; p=0.62), and length of hospital stay (HR 1.10, 95% CI 0.66-1.84; p=0.71). There were 22 pregnant women delivered 23 live births either by cesarean section (17, 60.7%) or vaginal delivery (5, 17.9%) and no neonate was infected with SARS-CoV-2. CONCLUSIONS: Pregnant women have comparable clinical course and outcomes compared with reproductive-aged non-pregnant women when infected with SARS-CoV-2. No evidence supported vertical transmission of COVID-19 in the late stage of pregnancy including vaginal delivery.","Int J Infect Dis","Qiancheng, Xu","Jian, Shen","Lingling, Pan","Lei, Huang","Xiaogan, Jiang","Weihua, Lu","Gang, Yang","Shirong, Li","Zhen, Wang","GuoPing, Xiong","Lei, Zha","32353549"],"abstract":["OBJECTIVES: This study aims to compare clinical course and outcomes between pregnant and reproductive-aged non-pregnant women with COVID-19 and assess the vertical transmission potential of COVID-19 in pregnancy. METHODS: Medical records of pregnant and reproductive-aged non-pregnant women hospitalized with COVID-19 from January 15 to March 15, 2020, were retrospectively reviewed. The severity of disease, virus clearance time, and length of hospital stay were measured as the primary interest and the vertical transmission potential of COVID-19 was also assessed. RESULTS: Eighty-two patients (28 pregnant women, 54 reproductive-aged non-pregnant women) with laboratory confirmed COVID-19 were enrolled in this study. Univariate regression indicated no association between pregnancy and the severity of disease (OR 0.73, 95% CI 0.08-5.15; p=0.76), virus clearance time (HR 1.16, 95% CI 0.65-2.01; p=0.62), and length of hospital stay (HR 1.10, 95% CI 0.66-1.84; p=0.71). There were 22 pregnant women delivered 23 live births either by cesarean section (17, 60.7%) or vaginal delivery (5, 17.9%) and no neonate was infected with SARS-CoV-2. CONCLUSIONS: Pregnant women have comparable clinical course and outcomes compared with reproductive-aged non-pregnant women when infected with SARS-CoV-2. No evidence supported vertical transmission of COVID-19 in the late stage of pregnancy including vaginal delivery."],"journal":"Int J Infect Dis","authors":["Qiancheng, Xu","Jian, Shen","Lingling, Pan","Lei, Huang","Xiaogan, Jiang","Weihua, Lu","Gang, Yang","Shirong, Li","Zhen, Wang","GuoPing, Xiong","Lei, Zha"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353549","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.ijid.2020.04.065","keywords":["covid-19","sars-cov-2","clinical feature","infection","pregnancy","virus"],"topics":["Transmission","Treatment","Diagnosis"],"weight":1,"_version_":1666138495661375492,"score":573.1045}]}